Headquarters in Geneva
Malaria parasite connecting to a red blood cell
A poster advertising trials of the RTS,S vaccine
Headquarters in Geneva
Main symptoms of malaria
RTS,S recombinant protein viruslike particle
Alexey Yablokov (left) and Vassili Nesterenko (farthest right) protesting in front of the World Health Organization headquarters in Geneva, Switzerland in 2008.
The life cycle of malaria parasites. Sporozoites are introduced by a mosquito bite. They migrate to the liver, where they multiply into thousands of merozoites. The merozoites infect red blood cells and replicate, infecting more and more red blood cells. Some parasites form gametocytes, which are taken up by a mosquito, continuing the life cycle.
Demonstration on Chernobyl disaster day near WHO in Geneva
Micrograph of a placenta from a stillbirth due to maternal malaria. H&E stain. Red blood cells are anuclear; blue/black staining in bright red structures (red blood cells) indicate foreign nuclei from the parasites.
Three former directors of the Global Smallpox Eradication Programme read the news that smallpox had been globally eradicated, 1980
Electron micrograph of a Plasmodium falciparum-infected red blood cell (center), illustrating adhesion protein "knobs"
Countries by World Health Organization membership status
The blood film is the gold standard for malaria diagnosis.
Stairwell, 1969
Ring-forms and gametocytes of Plasmodium falciparum in human blood
Internal courtyard, 1969
An Anopheles stephensi mosquito shortly after obtaining blood from a human (the droplet of blood is expelled as a surplus). This mosquito is a vector of malaria, and mosquito control is an effective way of reducing its incidence.
Reflecting pool, 1969
Man spraying kerosene oil in standing water, Panama Canal Zone, 1912
Exterior, 1969
Walls where indoor residual spraying of DDT has been applied. The mosquitoes remain on the wall until they fall down dead on the floor.
From Southwest, 2013
A mosquito net in use.
Entrance hall, 2013
An advertisement for quinine as a malaria treatment from 1927.
Main conference room, 2013
Deaths due to malaria per million persons in 2012
Map of the WHO's regional offices and their respective operating regions.
Africa; HQ: Brazzaville, Republic of the Congo
Western Pacific; HQ: Manila, Philippines
Eastern Mediterranean; HQ: Cairo, Egypt
South East Asia; HQ: New Delhi, India
Europe; HQ: Copenhagen, Denmark
Americas; HQ: Washington, D.C., US
Past and current malaria prevalence in 2009
Ancient malaria oocysts preserved in Dominican amber
British doctor Ronald Ross received the Nobel Prize for Physiology or Medicine in 1902 for his work on malaria.
Chinese medical researcher Tu Youyou received the Nobel Prize for Physiology or Medicine in 2015 for her work on the antimalarial drug artemisinin.
Artemisia annua, source of the antimalarial drug artemisinin
U.S. Marines with malaria in a field hospital on Guadalcanal, October 1942
Members of the Malaria Commission of the League of Nations collecting larvae on the Danube delta, 1929
1962 Pakistani postage stamp promoting malaria eradication program
Malaria clinic in Tanzania
Child with malaria in Ethiopia
World War II poster
Disability-adjusted life year for malaria per 100,000 inhabitants in 2004
no data

In October 2021, the vaccine was endorsed by the World Health Organization (WHO) for "broad use" in children, making it the first malaria vaccine candidate, and first vaccine to address parasitic infection, to receive this recommendation.


Its current priorities include communicable diseases, particularly HIV/AIDS, Ebola, COVID-19, malaria and tuberculosis; non-communicable diseases such as heart disease and cancer; healthy diet, nutrition, and food security; occupational health; and substance abuse.

- World Health Organization

As of 2012, the WHO was to report as to whether RTS,S/AS01, were a viable malaria vaccine.

- World Health Organization

In areas where malaria is common, the World Health Organization (WHO) recommends clinicians suspect malaria in any person who reports having fevers, or who has a current temperature above 37.5 °C without any other obvious cause.

- Malaria

As of 2020, there is one vaccine for malaria (known as RTS,S) which is licensed for use.

- Malaria
Headquarters in Geneva

1 related topic with Alpha


Screened cup of malaria-infected mosquitoes which will infect a volunteer in a clinical trial

Malaria vaccine

0 links

Screened cup of malaria-infected mosquitoes which will infect a volunteer in a clinical trial
RTS,S recombinant protein viruslike particle

A malaria vaccine is a vaccine that is used to prevent malaria.

The only approved vaccine, as of 2021, is RTS,S, known by the brand name Mosquirix.

It is the first vaccine that meets the World Health Organization's (WHO) goal of a malaria vaccine with at least 75% efficacy.